Many embodiments of wound filling devices and methods of their use in systems for the application of negative pressure therapy are described herein. In one embodiment, a wound filling device comprises: an inflatable bag member having at least one fluid carrying conduit operably connected thereto to inflate/deflate said bag member; a separate textured covering sock member at least partially covering the inflatable bag member. Another embodiment comprises a three-dimensional wound packing member, and may optionally comprise a plurality of such members linked together. Certain embodiments of wound packing members may comprise a porous bag member adapted to be non-adherent to the wound. Yet other embodiments may comprise a non-porous bag member provided with means to connect a fluid supply to the interior.

The present invention relates to an at least partly implantable system for injecting a substance into a patient's body. The system comprises at least one implantable infusion needle arranged in at least one first housing, the at least one implantable infusion needle having a tip end for injecting a substance into a penetration area of a patient, and at least one drive unit coupled to the at least one implantable infusion needle and arranged for moving the tip end of the at least one infusion needle for varying the penetration site, wherein the at least one drive unit is a drive unit arranged for moving the tip end of the at least one infusion needle using hydraulic force. The system is adapted to use infusion liquid to be injected into the patient's body as hydraulic fluid.

A blood warmer (10) has a first heating plate (12) and a second heating plate (14) as well as an exchangeable conductor (18, 20, 22, 24) for blood, which is arranged between the first heating plate (12) and the second heating plate (14). The blood warmer (10) has an inlet (66) and an outlet (68) for blood to which the conductor (18, 20, 22, 24) is fluidically connected. Due to the roughness of the surface (46) of the conductor (18, 20, 22, 24), an intermediate space (50) remains between the first heating plate (12) and/or the second heating plate (14) and the conductor (18, 20, 22, 24). A medium (52), which has a higher thermal conductivity than air, is at least partially statically arranged in the intermediate space (50). The blood warmer (10) may also have an electromechanical oscillating circuit and/or a vibration motor.

According to some embodiments, a system may treat blood outside the body of a patient. The system may include at least one toxin removal system configured to process blood from at least two places on the patient's body at a rate, for example, of at least 0.5 liters per minute. The system may be configured to raise the pH level of the patient's blood by introducing a fluid at rate of at least 9 liters per hour.

Method and device for treatment of a cutaneous surface or a mucous membrane. The device comprises a container, such as an aerosol can, for containing a composition comprising at least one refrigerant. The container has a container outlet and a valve communicating with the container outlet. An applicator is mounted or mountable to the container. The applicator comprises a heat exchanger, a contact surface and a dispensing channel between the container outlet and one or more applicator outlets arranged for wetting the contact surface. The dispensing channel defining a flow path crossing the heat exchanger. The contact surface can for example be formed by a non-porous layer, e.g. of plastic or rubber.

A mouth cooler is provided. The mouth cooler comprises a first peripheral cooling winding shaped and dimensioned to cool the lower and upper jaw, and at least one second cooling winding in arrangement with the peripheral cooling winding shaped and dimensioned to cool at least the blood entry to the tongue.

An injection tool and associated methods are shown. Example tools and methods described provide cooling to numb a local area prior to an injection. The local numbing can be used to reduce or eliminate pain associated with the subsequent injection. In selected examples, circuitry and one or more sensors are used to calculate an appropriate contact time of a heat sink with the local region to best provide a desired amount of numbing.

An embodiment includes a cardioplegia delivery system having a console, controller, and disposables. The system aides the perfusionist in cardioplegia delivery to the patient during Cardiopulmonary Bypass Surgery. The console, in conjunction with the disposables, combines blood from the heart-lung machine and crystalloid from the IV-bag in a specified ratio and then adds in a drug (arrest agent and/or additive). The electro-mechanical console incorporates a blood/crystalloid pump, temperature controllable water circulation system, pressure and temperature monitors, a sensor interface with the disposables, an arrest agent pump, an additive pump and ultra-sonic air detection sensors. The system monitors and controls the blood-crystalloid ratio, drug concentration, flow rate, pressure, temperature, and delivery route of the cardioplegia solution delivered to the patient. The system is a software-controlled system with a graphical user interface controller. The controller is utilized to initiate/stop cardioplegia delivery, monitor delivery parameters and view/save relevant case information and data.

An apparatus and method for the controlled acceleration, and/or retardation of the body's inflammatory response comprises a foam pad for insertion into a wound site, a drape covering the foam pad, and a thermal control element configured to be placed proximate the wound site. The foam pad is placed in fluid communication with a vacuum source for promotion of the controlled acceleration or retardation of the body's inflammatory response. The thermal control element has a pair of flexible sheets for receiving a thermally conductive fluid.

An improved system and methods for treatment of cancer and other diseases including complications from late-stage viral infections by inducing hyperthermia in a patient relying on withdrawing blood from the patient and returning the withdrawn blood to the patient to establish an extracorporeal flow circuit. Blood is heated by passing through the extracorporeal circuit at a controlled rate until a target body core temperature in is achieved. Usually, the blood will be subjected to a continuously re-circulating dialysis to balance electrolytes. Additionally, the blood will be subjected to a continuously recirculating regeneration through a carbon sorbent column where toxins and contaminants are removed. The blood temperature is maintained at the target blood temperature for a treatment period, and the blood is cooled after the treatment period has been completed. The method can also be effective in treating rheumatoid arthritis, scleroderma, hepatitis, sepsis, the Epstein-Barr virus, and patients with life threatening complications from other viruses, including the COVID-19 virus. A method for removing viruses from the blood supply in an external circuit is also presented. An adjunct of the present invention is enhanced production of stem cells as a result of employing the HEATT process. A further adjunct is production of transgenic swine with extant viral infections.